NCT02100540View on ClinicalTrials.gov

A Study to Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

March 19, 2014

Primary Completion Date

March 23, 2017

Study Completion Date

September 28, 2017

Conditions
PMSHot Flashes
Interventions
DRUG

I placebo capsule

I placebo capsule

DRUG

II RDC 0.3mg capsule

II RDC 0.3mg capsule

DRUG

III RDC 0.6mg capsule

III RDC 0.6mg capsule

Trial Locations (1)

135

Changhua Christian Hospital, Changhua

All Listed Sponsors
collaborator

Changhua Christian Hospital

OTHER

lead

Yung Shin Pharm. Ind. Co., Ltd.

INDUSTRY

NCT02100540 - A Study to Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women | Biotech Hunter | Biotech Hunter